{"id":135124,"date":"2021-05-31T15:28:08","date_gmt":"2021-05-31T09:58:08","guid":{"rendered":"https:\/\/apnlive.com\/?p=135124"},"modified":"2021-05-31T17:26:23","modified_gmt":"2021-05-31T11:56:23","slug":"centre-review-mix-covid-doses","status":"publish","type":"post","link":"https:\/\/apnlive.com\/latest-news\/centre-review-mix-covid-doses\/","title":{"rendered":"Centre looks to study mixing different Covid doses"},"content":{"rendered":"\n
The Central government is planning to study the mixing of two different Covid vaccine and also the effectiveness of a single dose of Covishield which is being used in two doses. Sources told that a study on mixing two different vaccines will start in a month and will likely be completed in two to two and half months.<\/p>\n\n\n\n
The Centre will assess vaccine data recorded on a new App, which will make it easier to report adverse events after vaccination. The platform, which is to be linked to CoWin, will allow people to flag their worries after a shot, after which a district officer will follow up on the cases. The effort is to make this a permanent platform that can be used for other new and emerging diseases that require vaccinations in the future.<\/p>\n\n\n\n
Recently, after 20 people were accidentally injected with two different vaccines, the centre had ruled out any cause for concern.<\/p>\n\n\n\n
The idea is to study aspects like breakthrough infections following vaccinations and the severity of infections post-immunisation. Another aim of the review is to understand whether a single dose is effective.<\/p>\n\n\n\n
Johnson and Johnson\u2019s single-dose vaccine is also based on the viral vector platform, while the two-dose Sputnik vaccine \u2014 based on the same technology \u2014 is now also being offered as a single-dose option.<\/p>\n\n\n\n
A single-dose regimen would help the government cover the population faster with its vaccination drive, which has slowed down due to a shortage.<\/p>\n\n\n\n
Covishield is the Indian version of the AstraZeneca-Oxford University vaccine. Incidentally, at the same time that India decided to increase the dosing interval for Covishield to 12 weeks citing real-life evidence from the UK that has reduced the dosing interval of the AstraZeneca vaccine to eight weeks to ensure the full protection of its vulnerable population.<\/p>\n\n\n\n
A study presented to the UK government emphasized that two doses provided better protection against specific variants of the virus than a single dose.<\/p>\n\n\n\n